BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481907. A total of 3 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $66,000 | -27.5% | 517 | -40.9% | 0.00% | – |
Q3 2019 | $91,000 | +911.1% | 875 | +1408.6% | 0.00% | – |
Q2 2019 | $9,000 | -72.7% | 58 | -42.0% | 0.00% | – |
Q1 2019 | $33,000 | +725.0% | 100 | +566.7% | 0.00% | – |
Q4 2018 | $4,000 | -87.5% | 15 | -71.7% | 0.00% | – |
Q3 2018 | $32,000 | -57.9% | 53 | -48.5% | 0.00% | – |
Q2 2018 | $76,000 | +3700.0% | 103 | -12.0% | 0.00% | – |
Q1 2018 | $2,000 | -90.5% | 117 | -30.8% | 0.00% | -100.0% |
Q4 2017 | $21,000 | -77.2% | 169 | -44.6% | 0.00% | -75.0% |
Q3 2017 | $92,000 | +384.2% | 305 | -6.7% | 0.00% | +300.0% |
Q2 2017 | $19,000 | – | 327 | +3170.0% | 0.00% | – |
Q1 2017 | $0 | – | 10 | -81.5% | 0.00% | – |
Q4 2016 | $0 | – | 54 | +500.0% | 0.00% | – |
Q3 2016 | $0 | -100.0% | 9 | -94.9% | 0.00% | -100.0% |
Q4 2015 | $10,000 | +233.3% | 176 | +780.0% | 0.00% | – |
Q3 2015 | $3,000 | -83.3% | 20 | -76.2% | 0.00% | -100.0% |
Q2 2015 | $18,000 | – | 84 | +4100.0% | 0.00% | – |
Q1 2015 | $0 | – | 2 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 526 | $764,000 | 0.03% |
SIMPLEX TRADING, LLC | 20 | $3,000 | 0.00% |
Citadel Advisors | 10,800 | $157,000 | 0.00% |